These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 3089683

  • 1. Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
    el-Raghy I, Back DJ, Makeram M, Salem H, Osman F, Fathalla M, Orme ML.
    Contraception; 1986 Apr; 33(4):379-84. PubMed ID: 3089683
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine.
    Back DJ, Breckenridge AM, Grimmer SF, Orme ML, Purba HS.
    Contraception; 1984 Sep; 30(3):289-95. PubMed ID: 6439467
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W, al-Yacoub G, Fuhrmeister A.
    Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
    [Abstract] [Full Text] [Related]

  • 5. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL, Roy S, Lobo RA.
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
    Kanarkowski R, Tornatore KM, D'Ambrosio R, Gardner MJ, Jusko WJ.
    Clin Pharmacol Ther; 1988 Jan; 43(1):23-31. PubMed ID: 3121231
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 8. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun 15; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 9. Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.
    Back DJ, Houlgrave R, Tjia JF, Ward S, Orme ML.
    J Steroid Biochem Mol Biol; 1991 Feb 15; 38(2):219-25. PubMed ID: 2004043
    [Abstract] [Full Text] [Related]

  • 10. Contraceptive steroid concentrations in women with early active schistosomiasis: lack of effect of antischistosomal drugs.
    el-Raghy I, Back DJ, Osman F, Orme ML, Fathalla M.
    Contraception; 1986 Apr 15; 33(4):373-7. PubMed ID: 3089682
    [Abstract] [Full Text] [Related]

  • 11. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES, Cruickshank J, McMaster M, Weir RJ.
    Br J Obstet Gynaecol; 1984 Dec 15; 91(12):1254-60. PubMed ID: 6440589
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
    Brenner PF, Goebelsmann U, Stanczyk FZ, Mishell DR.
    Contraception; 1980 Jul 15; 22(1):85-95. PubMed ID: 7418409
    [Abstract] [Full Text] [Related]

  • 13. Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.
    Rogers SM, Back DJ, Stevenson PJ, Grimmer SF, Orme ML.
    Br J Clin Pharmacol; 1987 Jun 15; 23(6):721-5. PubMed ID: 3111513
    [Abstract] [Full Text] [Related]

  • 14. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL, Langley MS, Robinson PA, Nummi S, Lund L.
    Fertil Steril; 1984 Jul 15; 42(1):44-51. PubMed ID: 6233179
    [Abstract] [Full Text] [Related]

  • 15. The relative bioavailability of levonorgestrel and ethinyl estradiol administered as a low-dose combination oral contraceptive.
    Goebelsmann U, Hoffman D, Chiang S, Woutersz T.
    Contraception; 1986 Oct 15; 34(4):341-51. PubMed ID: 3096634
    [Abstract] [Full Text] [Related]

  • 16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Oct 15; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 17. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE, Doose DR, Walker SA, Nayak RK.
    Epilepsia; 1997 Mar 15; 38(3):317-23. PubMed ID: 9070594
    [Abstract] [Full Text] [Related]

  • 18. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
    Toddywalla VS, Mehta S, Virkar KD, Saxena BN.
    Contraception; 1980 Mar 15; 21(3):217-23. PubMed ID: 7389350
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
    Carol W, Klinger G, Jäger R, Kasch R, Brandstädt A.
    Exp Clin Endocrinol; 1992 Mar 15; 99(1):12-7. PubMed ID: 1628691
    [Abstract] [Full Text] [Related]

  • 20. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S, Elicio N, Cordera R, Gapitanio GL, Montagna G, Croce S, Saturnino M, Balestreri R, De Cecco L.
    Acta Obstet Gynecol Scand; 1987 Mar 15; 66(4):327-32. PubMed ID: 2962417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.